Many studies have demonstrated that Chi3l1 is a reliable biomarker and promising therapeutic target for blood vessel-related inflammatory diseases such as atherosclerosis, coronary artery disease, stroke, and hypertension (Figure 1) [104]. Here, CHI3L1 is linked to stroke disorder.